Effect of Diaphragm Manual Therapy in Stroke patients

Not Applicable

Conditions: Health Condition 1: G969- Disorder of central nervous system, unspecified

Registration Number: CTRI/2024/03/063612

Lead Sponsor: Datta Meghe Institute of Higher Education and Research (DU)

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Open to Recruitment

Sex: Not specified

Target Recruitment: 0

Inclusion Criteria

1.Diagnosis of Hemiplegic Stroke: Individuals with a confirmed diagnosis of hemiplegic stroke.

2.Adequate Cognitive Function: Participants must have sufficient cognitive function to understand and comply with the study requirements.

3.Time Since Stroke: Inclusion of participants who are within a specific time frame since the onset of stroke (e.g., between 3 and 12 months) to ensure a relatively homogenous sample.

4.Stable Medical Condition: Participants should be in a stable medical condition, without acute medical complications.

5.Trunk Impairments: Presence of trunk impairments, including but not limited to muscle weakness, limited range of motion, and coordination deficits.

6.Willingness to Participate: Willingness to participate in the study and adhere to the prescribed diaphragm manual therapy intervention and assessment protocols.

Exclusion Criteria

1.Other Neurological Conditions: Exclusion of individuals with neurological conditions other than hemiplegic stroke.

2.Severe Cognitive Impairment: Exclusion of participants with severe cognitive impairment that may hinder their ability to comprehend and follow study instructions.

3.Unstable Medical Condition: Exclusion of individuals with unstable medical conditions, including uncontrolled hypertension or cardiac issues.

4.Pregnancy: Exclusion of pregnant individuals due to potential contraindications or safety concerns related to diaphragm manual therapy.

5.Previous Diaphragm Manual Therapy Within Study Period: Exclusion of participants who have undergone diaphragm manual therapy within a specified period before the study to avoid potential carryover effects.

6.Inability to Attend Sessions: Exclusion of individuals who are unable to attend the scheduled therapy sessions consistently.

7.Participation in Concurrent Clinical Trials: Exclusion of participants currently involved in other clinical trials to avoid potential confounding effects.